These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 12739340

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence?
    Juweid ME.
    J Nucl Med; 2008 Jan; 49(1):9-12. PubMed ID: 18077522
    [No Abstract] [Full Text] [Related]

  • 4. FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma.
    Kasamon YL, Wahl RL.
    Curr Opin Oncol; 2008 Mar; 20(2):206-19. PubMed ID: 18300772
    [Abstract] [Full Text] [Related]

  • 5. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
    Nuutinen J, Minn H, Bergman J, Haaparanta M, Ruotasalainen U, Laine H, Knuuti J.
    Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
    [Abstract] [Full Text] [Related]

  • 6. Evidence for a cardiac metabolic switch in patients with Hodgkin's lymphoma.
    Heckmann MB, Totakhel B, Finke D, Anker MS, Müller-Tidow C, Haberkorn U, Katus HA, Lehmann LH.
    ESC Heart Fail; 2019 Aug; 6(4):824-829. PubMed ID: 31278857
    [Abstract] [Full Text] [Related]

  • 7. Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
    Becherer A, Mitterbauer M, Jaeger U, Kalhs P, Greinix HT, Karanikas G, Pötzi C, Raderer M, Dudczak R, Kletter K.
    Leukemia; 2002 Feb; 16(2):260-7. PubMed ID: 11840293
    [Abstract] [Full Text] [Related]

  • 8. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.
    Even-Sapir E, Lievshitz G, Perry C, Herishanu Y, Lerman H, Metser U.
    Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534
    [Abstract] [Full Text] [Related]

  • 9. The use of interim (18)F-fluorodeoxyglucose PET to guide therapy in lymphoma.
    Araf S, Montoto S.
    Future Oncol; 2013 Jun; 9(6):807-15. PubMed ID: 23718301
    [Abstract] [Full Text] [Related]

  • 10. Hodgkin's and non-Hodgkin's lymphomas.
    Rademaker J.
    Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic value of FDG-PET in malignant lymphoma.
    Becherer A, Jaeger U, Szabo M, Kletter K.
    Q J Nucl Med; 2003 Mar; 47(1):14-21. PubMed ID: 12714950
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation.
    Svoboda J, Andreadis C, Elstrom R, Chong EA, Downs LH, Berkowitz A, Luger SM, Porter DL, Nasta S, Tsai D, Loren AW, Siegel DL, Glatstein E, Alavi A, Stadtmauer EA, Schuster SJ.
    Bone Marrow Transplant; 2006 Aug; 38(3):211-6. PubMed ID: 16770314
    [Abstract] [Full Text] [Related]

  • 18. Assessment of Lymphoma Therapy Using (18)F-FDG PET.
    Lowe VJ, Wiseman GA.
    J Nucl Med; 2002 Aug; 43(8):1028-30. PubMed ID: 12163627
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma.
    Cremerius U, Fabry U, Neuerburg J, Zimny M, Bares R, Osieka R, Büll U.
    Nuklearmedizin; 2001 Feb; 40(1):23-30. PubMed ID: 11373935
    [Abstract] [Full Text] [Related]

  • 20. [Current status of nuclear medicine. Clinical application of FDG-PET for cancer diagnosis. Malignant lymphoma].
    Higuchi T.
    Nihon Igaku Hoshasen Gakkai Zasshi; 2002 May; 62(6):278-83. PubMed ID: 12073634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.